Strengthening the Front Lines: New NIHR Funding for Adaptive Clinical Trials Contracts + Grants May 6, 2025 …
Tecovirimat Shown to Lack Efficacy as Treatment for Clade II Mpox Medical Countermeasures March 12, 2025 …
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health Emergencies Contracts + Grants August 27, 2024 …
Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development Medical Countermeasures December 27, 2022 …
NIH Begins Clinical Trial of Intradermal Monkeypox Vaccine Delivery to Expand Supply Medical Countermeasures September 8, 2022 …
New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines Medical Countermeasures March 19, 2022 …
Zika Virus Vaccine Shows Promising Results in Preclinical Studies Medical Countermeasures February 6, 2022 …
Phase 1 Trial Begins for Oxford University’s ChAdOx1 Plague Vaccine Medical Countermeasures July 26, 2021 …
Nanoparticle Mosaic Quadrivalent Flu Vaccine Phase 1 Clinical Trial Gets Underway Medical Countermeasures June 1, 2021 …
Inovio Considers Moving COVID-19 Vaccine Trial Overseas as U.S. Ends Funding Medical Countermeasures April 23, 2021 …
University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals Industry News April 15, 2021 …
National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder Medical Countermeasures April 7, 2021 …
